UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2021-12, Vol.73 (12), p.2338-2347

2021

Volltextzugriff (PDF)

Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide

Arthritis care & research (2010), 2022-03, Vol.74 (3), p.433-441

2022

Volltextzugriff (PDF)

Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2020-11, Vol.72 (11), p.1897-1904

2020

Volltextzugriff (PDF)

Contribution of Sex and Autoantibodies to Microangiopathy Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: A Systematic Review of the Literature

Arthritis care & research (2010), 2021-05, Vol.73 (5), p.722-731

2021

Volltextzugriff (PDF)

Physical Therapy in Systemic Sclerosis: The Patient Perspective

Arthritis care & research (2010), 2023-01, Vol.75 (1), p.145-151

2023

Volltextzugriff (PDF)

Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis

Arthritis care & research (2010), 2022-11, Vol.74 (11), p.1806-1812

2022

Volltextzugriff (PDF)

Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients

Scientific reports, 2019-03, Vol.9 (1), p.4521, Article 4521

2019

Volltextzugriff (PDF)

Consensus‐based recommendations on communication and education regarding primary care physical therapy for patients with systemic sclerosis

Musculoskeletal care, 2023-03, Vol.21 (1), p.45-55

2023

Volltextzugriff (PDF)

Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group study

Musculoskeletal care, 2020-06, Vol.18 (2), p.177-186

2020

Volltextzugriff (PDF)

Whole body insulin sensitivity is increased in systemic sclerosis

PloS one, 2023-03, Vol.18 (3), p.e0283283-e0283283

2023

Volltextzugriff (PDF)

Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis

Seminars in arthritis and rheumatism, 2023-02, Vol.58, p.152136-152136, Article 152136

2023

Volltextzugriff (PDF)

Anti-carbamylated protein antibodies in systemic sclerosis

Arthritis research & therapy, 2023-07, Vol.25 (1), p.123-123, Article 123

2023

Volltextzugriff (PDF)

Pulmonary Vascular Morphology Associated With Gas Exchange in Systemic Sclerosis Without Lung Fibrosis

Journal of thoracic imaging, 2019-11, Vol.34 (6), p.373

2019

Volltextzugriff (PDF)

Exploring the effects of a combined exercise programme on pain and fatigue outcomes in people with systemic sclerosis: study protocol for a large European multi-centre randomised controlled trial

Trials, 2022-11, Vol.23 (1), p.962-962, Article 962

2022

Volltextzugriff (PDF)

Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation

Frontiers in immunology, 2022-07, Vol.13, p.923869-923869

2022

Volltextzugriff (PDF)

Lung function is associated with minimal EQ-5D changes over time in patients with systemic sclerosis

Clinical rheumatology, 2020-05, Vol.39 (5), p.1543-1549

2020

Volltextzugriff (PDF)

Automatic Pulmonary Function Estimation From Chest CT Scans Using Deep Regression Neural Networks: The Relation Between Structure and Function in Systemic Sclerosis

IEEE access, 2023, Vol.11, p.135272-135282

2023

Volltextzugriff (PDF)

Worldwide Expert Agreement on Updated Recommendations for the Treatment of Systemic Sclerosis

Journal of rheumatology, 2020-02, Vol.47 (2), p.249

2020

Volltextzugriff (PDF)

Interstitial Lung Disease: How Should Therapeutics Be Implemented?

Rheumatic diseases clinics of North America, 2023-05, Vol.49 (2), p.279-293

2023

Volltextzugriff (PDF)

Lung structure and function relation in systemic sclerosis: Application of lung densitometry

European journal of radiology, 2015-05, Vol.84 (5), p.975-979

2015

Volltextzugriff (PDF)

Riociguat in systemic sclerosis: challenges in crossing the bridge from bench to bedside

The Lancet. Rheumatology, 2023-11, Vol.5 (11), p.e641-e643

de Vries-Bouwstra, Jeska K

2023

Volltextzugriff (PDF)

Rituximab in early systemic sclerosis

Rheumatic & musculoskeletal diseases open, 2017-07, Vol.3 (2), p.e000384-e000384

2017

Volltextzugriff (PDF)

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

Rheumatic & musculoskeletal diseases open, 2023-02, Vol.9 (1), p.e002827

2023

Volltextzugriff (PDF)

Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease

Autoimmunity reviews, 2024-06, Vol.23 (6), p.103582, Article 103582

2024

Volltextzugriff (PDF)

The Prognostic Value of Right Atrial and Right Ventricular Functional Parameters in Systemic Sclerosis

Frontiers in cardiovascular medicine, 2022-03, Vol.9, p.845359-845359

2022

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(89)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(71)
Rheumatology
(58)
Humans
(56)
Systemic Sclerosis
(46)
Female
(35)
Male
(34)
Middle Aged
(27)
Scleroderma
(27)
Adult
(23)
Aged
(16)
Patients
(13)
Arthritis, Rheumatoid - Drug Therapy
(11)
Autoantibodies
(11)
Quality Of Life
(10)
Scleroderma, Systemic - Complications
(10)
Scleroderma, Systemic - Diagnosis
(10)
Disease Progression
(9)
Severity Of Illness Index
(9)
Biological And Medical Sciences
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis

Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide

Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis

Contribution of Sex and Autoantibodies to Microangiopathy Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: A Systematic Review of the Literature

Physical Therapy in Systemic Sclerosis: The Patient Perspective

Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis

Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients

Consensus‐based recommendations on communication and education regarding primary care physical therapy for patients with systemic sclerosis

Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group study

Whole body insulin sensitivity is increased in systemic sclerosis

Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis

Anti-carbamylated protein antibodies in systemic sclerosis

Pulmonary Vascular Morphology Associated With Gas Exchange in Systemic Sclerosis Without Lung Fibrosis

Exploring the effects of a combined exercise programme on pain and fatigue outcomes in people with systemic sclerosis: study protocol for a large European multi-centre randomised controlled trial

Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation

Lung function is associated with minimal EQ-5D changes over time in patients with systemic sclerosis

Automatic Pulmonary Function Estimation From Chest CT Scans Using Deep Regression Neural Networks: The Relation Between Structure and Function in Systemic Sclerosis

Worldwide Expert Agreement on Updated Recommendations for the Treatment of Systemic Sclerosis

Interstitial Lung Disease: How Should Therapeutics Be Implemented?

Lung structure and function relation in systemic sclerosis: Application of lung densitometry

Riociguat in systemic sclerosis: challenges in crossing the bridge from bench to bedside

Rituximab in early systemic sclerosis

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease

The Prognostic Value of Right Atrial and Right Ventricular Functional Parameters in Systemic Sclerosis

Suchergebnisse filtern